The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection
Abstract
Background/aims New lesions recur within weeks to months after ileal resection and ileocolonic anastomosis for Crohn's ileitis. A double-blind controlled trial was performed using metronidazole to prevent recurrence after ileal resection.Methods Sixty patients who underwent curative ileal resection and primary anastomosis were included within 1 week after surgery. Thirty patients received metronidazole (20 mg/kg body wt) daily for 3 months, and 30 patients received placebo. Treatment was then discontinued. Nine patients dropped out during treatment, 7 in the metronidazole group and 2 in the placebo arm.Results At 12 weeks, 21 of 28 patients (75%) in the placebo group had recurrent lesions in the neoterminal ileum as compared with 12 of 23 patients (52%) in the metronidazole group (P = 0.09). The incidence of severe endoscopic recurrence was significantly reduced by metronidazole (3 of 23; 13%) as compared with placebo (12 of 28; 43%; P = 0.02). Patients in the metronidazole arm had more frequent side effects. Metronidazole therapy statistically reduced the clinical recurrence rates at 1 year (4% vs. 25%). Reductions at 2 years (26% vs. 43%) and 3 years (30% vs. 50%) were not significant.Conclusions Metronidazole therapy for 3 months decreases the severity of early recurrence of Crohn's disease in the neoterminal ileum after resection and seems to delay symptomatic recurrence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients who have had a resection for CD have a decreased rate of endoscopic and clinical recurrence when metronidazole or ornidazole are used as prophylactic therapies.78”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [78]
In the citing paper
“Antibiotics demonstrate efficacy in particular groups of patients with CD”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [78]
Citations
Cites
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. I. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,814
Self-citationNatural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.
Rutgeerts, P., Geboes, K. P., Vantrappen, G. R., Kerremans, R., Coenegrachts, J. L., & Coremans, G. (1984) · Gut · doi:10.1136/gut.25.6.665 · Cited by 785
Self-citationEffect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M. I., Vantrappen, G. R., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 758
Self-citationDouble blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland, L. R., Singleton, J., Sessions, J. T., Hanauer, S., Krawitt, E. L., Rankin, G. B., Summers, R. J., Mekhjian, H. S., Greenberger, N. J., & Kelly, M. (1991) · Gut · doi:10.1136/gut.32.9.1071 · Cited by 527
Olaison, G., Smedh, K., & Sjödahl, R. (1992) · Gut · doi:10.1136/gut.33.3.331 · Cited by 497
Healing of perineal Crohn's disease with metronidazole
Bernstein, L. H., Frank, M. S., Brandt, L. J., & Boley, S. J. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90155-9 · Cited by 440
Confidence Intervals for Reporting Results of Clinical Trials
Simon, R. M. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-429 · Cited by 410
Ursing, B., Alm, T., Bárány, F., Bergelin, I. S. S., Ganrot-Norlin, K., Hoevels, J., Huitfeldt, B., Järnerot, G., Krause, U., Krook, A. L., et al. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80189-3 · Cited by 351
Controlled trial of bowel rest and nutritional support in the management of Crohn's disease
Greenberg, G. R., Fleming, C. R., Jeejeebhoy, K. N., Rosenberg, I. H., Sales, D., & Tremaine, W. J. (1988) · Gut · doi:10.1136/gut.29.10.1309 · Cited by 296
Sample Size Nomograms For Interpreting Negative Clinical Studies
Young, M., Bresnitz, E. A., & Strom, B. L. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-248 · Cited by 251
Research works printed but not linked: 1
- Malchow, 1987, The early signs of Crohn's disease after surgery: a prospective trial, Gastrointest Endosc, 33, 163
Cited by
Sorted by citations
Items 401–500 of 741
The Management of Postoperative Recurrence in Crohn’s Disease
Fasulo, E., D’Amico, F., Osorio, L., Allocca, M., Fiorino, G., Zilli, A., Parigi, T. L., Danese, S., & Furfaro, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010119 · Cited by 17
“Nevertheless, adverse events (including gastrointestinal intolerance, limb paraesthesia, abnormal liver function, leukopenia, polyneuropathy, and psychosis) were more frequent, leading to treatment discontinuation in about 30% of patients [90].”
BackgroundMedical management of Crohn's disease
Cottone, M., Renna, S., Orlando, A., & Mocciaro, F. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.609556 · Cited by 17
“In the first trial [124], 60 patients were randomized to receive metronidazole (20 mg/kg) or placebo for 3 months and then were followed up for 3 years.”
BackgroundDilger, K., Fux, R., Röck, D., Mörike, K., & Gleiter, C. H. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007308617 · Cited by 17
Effect of the Macrolide Antibacterial Drug, Tylosin, on TNBS-Induced Colitis in the Rat
Menozzi, A., Pozzoli, C., Poli, E., Lazzaretti, M., Cantoni, A. M., Grandi, D., Giovannini, E., & Coruzzi, G. (2005) · Pharmacology · doi:10.1159/000084324 · Cited by 17
Can the Standard Gamble Be Used to Determine Utilities for Uncertain Health States?
Kennedy, E. D., Detsky, A. S., Llewellyn‐Thomas, H. A., O’Connor, B. I., Varkul, M., Steinhart, A. H., Cohen, Z., & McLeod, R. S. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000109 · Cited by 17
The management of severe Crohn’s disease
Parkes, M., & Jewell, D. P. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00963.x · Cited by 17
NEWER TREATMENTS FOR INFLAMMATORY BOWEL DISEASE
Stotland, B. R., & Lichtenstein, G. R. (1996) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70349-3 · Cited by 17
Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease
Hashash, J. G., Chintamaneni, P., Rivers, C. R., Κoutroubakis, I. E., Regueiro, M. D., Baidoo, L., Swoger, J. M., Barrie, A. M., Schwartz, M. B., Dunn, M. A., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000534 · Cited by 16
“In comparison with other antibiotics, the more frequent utilization of metronidazole and fluoroquinolones in patients with IBD is not surprising as their role in the management of IBD, and its complications is well established in the literature.(13,15,23) In our cohort, antibiotic-exposed patients were more likely to…”
ResultThe Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn’s Disease
Yamada, A., Komaki, Y., Komaki, F., Haider, H., Micić, D., Pekow, J. R., Dalal, S. R., Cohen, R. D., Cannon, L. M., Umanskiy, K., et al. (2021) · Digestion · doi:10.1159/000513589 · Cited by 16
Workshop Report: Prevention of Postoperative Recurrence in Crohn's Disease
Markowitz, J. F., Markowitz, J. E., Bousvaros, A., Crandall, W., Faubion, W. A., Kirschner, B. S., Perrault, J. F., Rosh, J. R., & Winter, H. S. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000172746.86973.ef · Cited by 16
“In a trial of 60 patients undergoing curative resection, a 3 month trial of metronidazole was shown to reduce the rates of endoscopic recurrence (using the Rutgeerts criteria) (36).”
MethodMedical Management of Crohn's Disease
Feldman, P., Wolfson, D. L., & Barkin, J. S. (2007) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-2007-991026 · Cited by 15
Update in Medical Treatment of Crohn's Disease
Regueiro, M. D. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200012000-00004 · Cited by 15
“Only one trial has demonstrated a benefit of metronidazole in reducing the recurrence of Crohn’s disease after ileal resection.(43) Ciprofloxacin may also be effective in the treatment of active Crohn’s disease.”
BackgroundWall, G. C., Heyneman, C. A., & Pfanner, T. P. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.15.1138.30574 · Cited by 15
“19 Patients with both ileal and colonic disease may respond to the drug, and it is particularly effective for maintenance therapy in postoperative patients.(49) Long-term therapy is required to keep patients in remission.”
Background9 Prognostic parameters of Crohn's disease recurrence
Strong, S. A. (1998) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(98)90091-4 · Cited by 15
Promotion of a Favorable Gut Flora in Inflammatory Bowel Disease
Kennedy, R. J., Kirk, S. J., & Gardiner, K. R. (2000) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607100024003189 · Cited by 14
Antibiotic Use in Crohnʼs Disease
Prantera, C., Scribano, M. L., Berto, E., & Zannoni, F. (1997) · BioDrugs · doi:10.2165/00063030-199708040-00005 · Cited by 15
Controversies in Pediatric Inflammatory Bowel Disease
Cohen, M. B., Seidman, E. G., Winter, H. S., Colletti, R. B., Kirschner, B. S., Balistreri, W. F., & Grand, R. J. (1998) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780040306 · Cited by 16
Management of Postoperative Recurrence of Crohn's Disease
van Lent, A. U., & D’Haens, G. (2013) · Digestive Diseases · doi:10.1159/000353374 · Cited by 14
The role of antimicrobials in Crohn’s disease
Kale-Pradhan, P. B., Zhao, J., Palmer, J. R., & Wilhelm, S. M. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.13.6 · Cited by 14
“Rutgeerts et al. (1995) 51 MTZ 20 mg/kg daily or placebo ×3 months Only antidiarrhial drugs were allowed, steroids were tapered and stopped within 4 weeks after surgery Endoscopic recurrent lesions at 3 months: MTZ: 52%; placebo: 75% (p = 0.”
BackgroundInfluentialBorowiec, A. M., Sydora, B. C., Doyle, J. S. G., Guan, L. L., Churchill, T. A., Madsen, K. L., & Fedorak, R. N. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.01.048 · Cited by 14
“[12] Rutgeerts P, Hiele M, Geboes K, et al.”
BackgroundCabré, E., & Gassull, M. A. (2007) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2007.06.003 · Cited by 14
Sakuraba, A., Okamoto, S., Matsuoka, K., Sato, T., Naganuma, M., Hisamatsu, T., Iwao, Y., Ogata, H., Kanai∥, T., & Hibi∥, T. (2015) · Digestion · doi:10.1159/000375302 · Cited by 14
Assessing disease activity and disease activity indices for inflammatory bowel disease
Li, F. X., & Sutherland, L. R. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0025-z · Cited by 14
Antibiotics are effective therapy for Crohn's disease
Peppercorn, M. A. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030411 · Cited by 14
“Rutgeerts and colleagues have shown that ileal recurrence following resection and anastomosis can be delayed either by a proximal ileostomy diverting luminal contents (14) or by a brief postoperative course of metronidazole (15).”
BackgroundPostoperative Crohn’s disease: prevention and treatment
El‐Hachem, S., & Regueiro, M. D. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.21 · Cited by 14
MEDICAL THERAPY OF SPECIFIC CLINICAL PRESENTATIONS
Michetti, P., & Peppercorn, M. A. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70060-1 · Cited by 14
Domènech, E., Scala, L., Bernal, I., García-Planella, E., Casalots, Á., Piñol, M., Esteve, M., Cabré, E., Boix, J., & Gassull, M. À. (2004) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)70533-0 · Cited by 14
Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans
Kruiningen, H. J. V. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780050308 · Cited by 14
Borowiec, A. M., & Fedorak, R. N. (2011) · Canadian Journal of Gastroenterology · doi:10.1155/2011/591347 · Cited by 13
Role of conventional therapies in the era of biological treatment in Crohn’s disease
Gionchetti, P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i14.1797 · Cited by 13
Hanžel, J., Jairath, V., Cruz, P. P. D., Guizzetti, L., Shackelton, L. M., Bossuyt, P. J., Duijvestein, M., Dulai, P. S., Grossmann, J., Hirten, R. P., et al. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab259 · Cited by 13
Shen, F., Zhang, H.-J., Zhao, X.-D., Cao, R., & Shi, R.-H. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02965.x · Cited by 13
The Role of Anti(myco)bacterial Interventions in the Management of IBD: Is There Evidence at All?
de Chambrun, G. P. P., Torres, J., Darfeuille–Michaud, A., & Colombel, J. (2012) · Digestive Diseases · doi:10.1159/000338126 · Cited by 13
Bhasin, S., Singh, H., Targownik, L. E., Israeli, E., & Bernstein, C. N. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000753 · Cited by 13
Cost-effectiveness of Crohn’s disease post-operative care
Wright, E. K., Kamm, M. A., Cruz, P. P. D., Hamilton, A. L., Ritchie, K. J., Bell, S., Brown, S. J., Connell, W. R., Desmond, P. V., & Liew, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i14.3860 · Cited by 13
Postoperative Management of Crohn Disease
Cho, S. M., Cho, S. W., & Regueiro, M. D. (2009) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.07.008 · Cited by 13
Current Status of Surgery for Inflammatory Bowel Disease
Fazio, V. W. (1998) · Digestion · doi:10.1159/000007524 · Cited by 13
Targeting of Costimulatory Molecules as a Therapeutic Approach in Inflammatory Bowel Disease
Maerten, P., Liu, Z., & Ceuppens, J. L. (2003) · BioDrugs · doi:10.2165/00063030-200317060-00003 · Cited by 13
10 Adjuvant post-operative therapy
Leiper, K., London, I., & Rhodes, J. M. (1998) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(98)90092-6 · Cited by 13
Biomarkers That Predict Crohn’s Disease Outcomes
Olivera, P. A., & Silverberg, M. S. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad024 · Cited by 12
“78,79 Consequently, microbial signatures associated with POR that could potentially be used as biomarkers have been sought.”
BackgroundAntibiotics for inflammatory bowel disease: Current status
Jha, D. K., Mishra, S., Dutta, U., & Sharma, V. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01537-x · Cited by 12
“%) as compared with placebo (12 of 28; 43%; p = 0.02) and in a second trial, where ornidazole was used for prophylaxis noted a significant reduction of both clinical (37.5% vs. 7.9%, p =0.004) and endoscopic (53.6% vs. 79%, p =0.037) recurrence at one year, as compared to placebo [69, 70].”
InfluentialPrediction and Prevention of Inflammatory Bowel Disease
Lopes, E. W., Turpin, W., Croitoru, K., Colombel, J., & Torres, J. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.047 · Cited by 13
The Gut Microbiota and Inflammatory Bowel Disease
Conrad, M. A., Wu, G. D., & Kelsen, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-49215-5_4 · Cited by 12
Anti-TNFα agents are the best choice in preventing postoperative Crohn’s disease: A meta-analysis
Erös, A., Farkas, N., Hegyi, P. J., Szabó, A., Balaskó, M., Veres, G., Czakó, L., Bajor, J., Alizadeh, H., Rakonczay, Z., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.027 · Cited by 12
Bemelman, W. A., Ivensky, M., van Hogezand, R. A., Hermans, J., Veenendaal, R. A., & Griffioen, G. G. (2001) · Digestive Surgery · doi:10.1159/000050098 · Cited by 12
INFLAMMATORY BOWEL DISEASE AND INTESTINAL CANCER
Moir, C. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6127-4.00042-2 · Cited by 12
Crohn's disease recurrence can be prevented after ileal resection
Rampton, D. S. (2002) · Gut · doi:10.1136/gut.51.2.153 · Cited by 12
Prevention of postoperative recurrence in Crohn’s disease
D’Haens, G. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0006-6 · Cited by 12
de Tena, J. G., Manzano, L., & Álvarez‐Mon, M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200212123472418 · Cited by 12
Clinical Update on the Prevention and Management of Postoperative Crohn’s Disease Recurrence
Bachour, S. P., & Click, B. H. (2024) · Current Gastroenterology Reports · doi:10.1007/s11894-023-00911-7 · Cited by 11
Optimizing post-operative Crohn's disease treatment.
Domènech, E., Mañosa, M., Lobatón, T., & Cabré, E. (2014) · Europe PMC (PubMed Central) · Cited by 11
Pathophysiology of Inflammatory Bowel Diseases
Hoentjen, F., & Dieleman, L. A. (2008) · CRC Press eBooks · doi:10.1201/9780849381829.ch17 · Cited by 11
Medical Therapy for Refractory Pediatric Crohn’s Disease
Faubion, W. A., & Bousvaros, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.031 · Cited by 11
Endoscopic Evaluation and Management of the Postoperative Crohn's Disease Patient
Hashash, J. G., & Binion, D. G. (2016) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2016.06.003 · Cited by 11
Postoperative Management of Crohn Disease
Cho, S. M., Cho, S. W., & Regueiro, M. D. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.08.019 · Cited by 11
“Compared with the placebo group, metronidazole significantly reduced the clinical recurrence rates at 1 year (4% vs 25%).(28) However, patients in the metronidazole arm experienced more frequent side effects (23.”
ResultInflammatory Bowel Diseases in the Elderly
Swaroop, P. P. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.06.007 · Cited by 11
Atuğ, Ö., Hamzaoğlu, H. Ö., Tahan, V., Ali̇can, İ., Kurtkaya, Ö., Elbüken, E., Özdogan, O. C., & Tozun, N. A. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9956-4 · Cited by 11
Kjeldsen, J., Nielsen, J., Larsen, M. D., Qvist, N., & Nørgård, B. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000647 · Cited by 11
Lichtenstein, G. R. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70327-1 · Cited by 11
3 Ulcerative colitis: an immunological disease?
Radford‐Smith, G. L. (1997) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(97)90052-x · Cited by 11
Medical treatment of Crohn's disease
Harrison, J., & Hanauer, S. B. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00011-5 · Cited by 11
“[109] Rutgeerts P, Hiele M, Geboes K, et al.”
BackgroundAntibiotics are not effective therapy for Crohn's disease (time to remove the rose-coloured glasses)
Feagan, B. G. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030410 · Cited by 11
“Rutgeerts and colleagues (6) randomly assigned 60 patients who had undergone resection of their terminal ileum to receive either 20 mgkg of metronidazole or a placebo for a period of 3 years.”
Background6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero
Seidman, E. G. (2000) · Gastroenterology · doi:10.1053/gast.2000.19601 · Cited by 11
Zhang, L., Jin, Z., & Jia, H. (2023) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_190_23 · Cited by 10
“[39] Studies have indicated that the top‑down approach primarily promotes deep and durable mucosal healing, thereby reducing complications and the need for surgical procedures.”
BackgroundZhao, B., Zhou, H., Lin, K., Xu, J., Zhou, B., Xie, D., Ma, J., Yang, L., Su, C., & Yang, L. (2025) · MedComm · doi:10.1002/mco2.70085 · Cited by 10
Updating predictors of endoscopic recurrence after ileocolic resection for Crohn disease
Monteiro, S., Gonçalves, T. C., Carvalho, P. B., Moreira, M. J., & Cotter, J. B. (2017) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2017.16721 · Cited by 10
“Several medications, such as mesalamine or antibiotics, have been advocated for the prevention of postoperative disease recurrence (28,29).”
BackgroundCeliac disease and inflammatory bowel disease in pregnancy
Carolis, S. D., Botta, A., Fatigante, G., Garofalo, S., Ferrazzani, S., Gasbarrini, A., & Caruso, A. (2004) · Lupus · doi:10.1191/0961203304lu1096oa · Cited by 10
Role of surgery in the management of Crohn's disease
Fichera, A., Schlottmann, F., Krane, M. K., Bernier, G. V., & Lange, E. O. (2018) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2018.05.001 · Cited by 10
POSTOPERATIVE PREVENTIVE TREATMENT OF CROHN'S DISEASE (review)
Халиф, И. Л., Vardanyan, A. V., Шапина, М. В., & Полетова, А. В. (2017) · Koloproktologia · doi:10.33878/2073-7556-2017-0-3-63-70 · Cited by 10
Beelen, E. M. J., de Vries, A. C., Bodelier, A. G. L., Moolenaar, J., Schouten, W. R., & van der Woude, C. J. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001551 · Cited by 10
Advances in IBD: Current Developments in the Treatment of Inflammatory Bowel Diseases.
(2009) · PubMed Central · Cited by 10
The use of probiotics in gastrointestinal diseases
Pagliaro, G., & Battino, M. A. (2010) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-010-0008-9 · Cited by 10
Papi, C., Aratari, A., Tornatore, V., Koch, M., Capurso, L., & Caprilli, R. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2008.12.001 · Cited by 10
Prevention of Relapse of Crohnʼs Disease
Sutherland, L. R. (2000) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780060410 · Cited by 10
Inflammatory bowel disease in women of reproductive age
Felice, K. M. D., & Kane, S. V. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.893822 · Cited by 10
“Metronidazole is used in perianal fistulizing CD and pouchitis, and in the prevention of postoperative recurrence of CD [30,31].”
BackgroundHepatic manifestations of non-steroidal inflammatory bowel disease therapy
Hirten, R. P. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i27.2716 · Cited by 10
4 Medical therapy of active Crohn's disease
Järnerot, G., Sandberg–Gertzén, H., & Tysk, C. (1998) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(98)90086-0 · Cited by 10
Antibiotics Are Not Effective Therapy for Crohnʼs Disease (Time to Remove the Rose-Coloured Glasses)
Feagan, B. G. (1997) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199712000-00009 · Cited by 10
Postoperative Crohn's disease management
Barnes, E. L. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000638 · Cited by 9
Comprehensive review and update of stricturing Crohn’s disease
Elford, A. T., Ardalan, Z. S., Simkin, P. M., & Christensen, B. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01508-8 · Cited by 9
“A three-month course of nitroimi-dazole antibiotics immediately post-operation has demonstrated efficacy in reducing post-operative recurrence [76, 77].”
Postoperative Crohn’s disease: how can we prevent it?
Swoger, J. M., & Regueiro, M. D. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.33 · Cited by 9
Guo, Z., Cai, X., Liu, R., Gong, J., Li, Y., Cao, L., Wang, Z., & Zhu, W. (2018) · Colorectal Disease · doi:10.1111/codi.14352 · Cited by 9
Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime?
Cheng, Y., & Fischer, M. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.08.006 · Cited by 10
New treatments for inflammatory bowel disease
Rampton, D. S. (1998) · World Journal of Gastroenterology · doi:10.3748/wjg.v4.i5.369 · Cited by 9
Antibiotics Are Effective Therapy for Crohnʼs Disease
Peppercorn, M. A. (1997) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199712000-00010 · Cited by 9
Novel Therapies for Crohn's Disease: Focus on Immunomodulators and Antibiotics
Wilhelm, S. M., Taylor, J. D., Osiecki, L. L., & Kale-Pradhan, P. B. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h038 · Cited by 9
The emerging therapeutic role of probiotics in inflammatory bowel disease.
Chandler, M. B., Wollins, E. R., Toles, A., Borum, M. L., & Doman, D. B. (2008) · Europe PMC (PubMed Central) · Cited by 9
The Treatment of Inflammatory Bowel Disease in Children
Wyllie, R., & Sarigol, S. S. (1998) · Clinical Pediatrics · doi:10.1177/000992289803700704 · Cited by 9
Andersen, K., Selvig, K. A., & Leknes, K. N. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.4.537 · Cited by 9
Newton, J. M., Edwards, W. J. S., Thompson, G. S., Gentekaki, E., & Tsaousis, A. D. (2025) · Access Microbiology · doi:10.1099/acmi.0.000926.v4 · Cited by 9
“Antibiotic administration has been an effective treatment for some IBS cases and other GI conditions, while metronidazole, ciprofloxacin and rifaximin have been effective at decreasing the severity of symptoms in many clinical trials [18, 19, 24–26].”
The impact of exclusive enteral nutrition on the intestinal microbiota in inflammatory bowel disease
Day, A. S. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.4.584 · Cited by 8
“Similarly, a prolonged period of antibiotics may delay the endoscopic recurrence of disease following a surgical resection [24].”
BackgroundUeda, T., Koyama, F., Sugita, A., Ikeuchi, H., Futami, K., Fukushima, K., Nezu, R., Iijima, H., Mizushima, T., Itabashi, M., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad116 · Cited by 8
Ong, M.-S., Grand, R. J., & Mandl, K. D. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000898 · Cited by 8
Zárubová, K., Hradský, O., Čopová, I., Rouskova, B., Poš, L., Škába, R., & Bronský, J. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001470 · Cited by 8
Schlussel, A. T., Cherng, N. B., & Alavi, K. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.04.016 · Cited by 8
Pharmacological Prevention and Management of Postoperative Relapse in Pediatric Crohn’s Disease
Yerushalmy‐Feler, A., & Assa, A. (2019) · Pediatric Drugs · doi:10.1007/s40272-019-00361-7 · Cited by 8
“Antibiotics Metronidazole 60 RCT Reduced risk of clinical and severe endoscopic recurrence [48]”
BackgroundSands, B. E., & Siegel, C. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00111-6 · Cited by 8
Zabana, Y., Mañosa, M., Cabré, E., Bernal, I., Marín, L., Lorenzo‐Zúñiga, V., Moreno, V., Boix, J., & Domènech, E. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12579 · Cited by 8
Medical therapy for Crohn’s disease
Hanauer, S. B., & Dassopoulos, T. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_33 · Cited by 8
Antibacterial and antimycobacterial treatment for inflammatory bowel disease
Ohkusa, T., & Sato, N. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03472.x · Cited by 8
Metadata
- Authors
- Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 108
- Issue
- 6
- Pages
- 1617-1621
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1980212383
- Cited by
- 743
- References
- 24
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 14 · 2023: 14 · 2022: 6 · 2021: 13 · 2020: 18 · 2019: 17 · 2018: 13 · 2017: 26 · 2016: 27 · 2015: 28 · 2014: 28 · 2013: 25 · 2012: 28
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Diverticular Disease and Complications
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- metronidazole, Crohn's disease, ileal resection, ileocolic anastomosis, postoperative recurrence, recurrence prevention, endoscopic recurrence
- MeSH terms
- Adult, Crohn Disease, Double-Blind Method, Follow-Up Studies, Humans, Ileum, Metronidazole, Middle Aged, Recurrence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
